Phase II study of intrathecal therapy with DepoCyt for active lymphomatous or leukemic meningitis.

Trial Profile

Phase II study of intrathecal therapy with DepoCyt for active lymphomatous or leukemic meningitis.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Jun 2013

At a glance

  • Drugs Cytarabine (Primary)
  • Indications Lymphomatous meningitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Aug 2010 Planned end date changed from 1 Jun 2012 to 1 Jun 2009 as reported by ClinicalTrials.gov.
    • 20 Aug 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 13 Aug 2008 Planned end date changed from 1 Jun 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top